Collagen-povidone for Diabetic Seniors' Tenosynovitis
Status:
COMPLETED
Trial end date:
2024-04-01
Target enrollment:
Participant gender:
Summary
Diabetes affects 415 million adults globally, leading to hand issues. Povidone collagen shows promise in managing tenosynovitis. A clinical trial was conduced to compared its efficacy in adults over 60. It is shown that the intervention reduces pain, improves functionality, and grip strength with no complications. Collagen povidone holds potential for treating diabetic hand issues.